Literature DB >> 7000906

Antibody-dependent cell-mediated antibacterial activity: K lymphocytes, monocytes, and granulocytes are effective against shigella.

G H Lowell, R P MacDermott, P L Summers, A A Reeder, M J Bertovich, S B Formal.   

Abstract

Normal human peripheral blood lymphocytes, monocytes, and granulocytes decreased the viability of Shigella flexneri in vitro in cooperation with heat-inactivated rabbit hyperimmune anti-shigella antisera. Purified K and T lymphocyte populations used before the removal of Fc receptor-bearing cells were effective in this antibody-dependent complement-free system. In contrast, B lymphocytes and T lymphocytes from which Fc receptor-bearing cells were removed exhibited no activity. In the absence of antisera, lymphocytes and monocytes were ineffective whereas granulocytes were only moderately effective even when cells from patients recently infected with shigella were used. Convalescent (but not pre-infection) sera from these patients, however, induced marked cell-mediated antibacterial activity against their homologous infecting shigella whether the cells were from uninfected or infected individuals. These data suggest that Fc receptor-bearing lymphocytes, monocytes, and granulocytes play a role in host immune defense against enteric pathogens such as shigella even in locations where complement may be functionally deficient such as among secretory mucosal surfaces.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000906

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Pulmonary infections in immunocompromised children.

Authors:  V P Choudhry; S Choudhary
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

2.  Destruction of the multicellular parasite Schistosoma mansoni by T lymphocytes.

Authors:  J J Ellner; G R Olds; C W Lee; M E Kleinhenz; K L Edmonds
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

3.  Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.

Authors:  Subhra Chakraborty; Clayton Harro; Barbara DeNearing; Jay Bream; Nicole Bauers; Len Dally; Jorge Flores; Lillian Van de Verg; David A Sack; Richard Walker
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

4.  Cytotoxicity of leukocytes from normal and Shigella-susceptible (opium-treated) guinea pigs against virulent Shigella sonnei.

Authors:  D R Morgan; H L DuPont; L V Wood; S Kohl
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

5.  Cytotoxicity of human peripheral blood and colostral leukocytes against Shigella species.

Authors:  D R Morgan; H L DuPont; B Gonik; S Kohl
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

6.  Shigella bacteraemia in adults.

Authors:  A J Trevett; B O Ogunbanjo; S Naraqi; J D Igo
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

7.  Antibacterial activity of human mononuclear leukocytes against Staphylococcus aureus.

Authors:  L Prokesová; D H Dung; I Trebichavský; E Formánková; V Stĕpánková; C John
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

8.  Functions of Antibodies.

Authors:  Donald N Forthal
Journal:  Microbiol Spectr       Date:  2014-08-15

9.  Phagocytosis of Giardia lamblia trophozoites by cytokine-activated macrophages.

Authors:  M Belosevic; C W Daniels
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

10.  Pretreatment with lipoteichoic acid sensitizes target cells to antibody-dependent cellular cytotoxicity in the presence of anti-lipoteichoic acid antibodies.

Authors:  D E Lopatin; R E Kessler
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.